235 related articles for article (PubMed ID: 3041245)
1. Hepatotoxicity of methotrexate in rheumatic diseases.
Kevat S; Ahern M; Hall P
Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
Szanto E; Sandstedt B; Kollberg B
Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
[TBL] [Abstract][Full Text] [Related]
4. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
5. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
Dahl MG; Gregory MM; Scheuer PJ
Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
[TBL] [Abstract][Full Text] [Related]
7. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
9. Longterm methotrexate therapy in rheumatoid arthritis: a review.
Kremer JM
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate hepatotoxicity.
West SG
Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
12. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
[TBL] [Abstract][Full Text] [Related]
13. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
Ezhilarasan D
Toxicology; 2021 Jun; 458():152840. PubMed ID: 34175381
[TBL] [Abstract][Full Text] [Related]
15. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
Thomas JA; Aithal GP
Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
[TBL] [Abstract][Full Text] [Related]
16. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
Themido R; Loureiro M; Pecegueiro M; Brandão M; Campos MC
Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate therapy in rheumatoid arthritis: 15 years experience.
Hoffmeister RT
Am J Med; 1983 Dec; 75(6A):69-73. PubMed ID: 6660241
[TBL] [Abstract][Full Text] [Related]
20. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
